Business Signals Copy RSS link Link copied to clipboard!
UBS Group AG reduces Arch Capital Group Ltd holdings by 41.5%
UBS Group AG decreased its stake in Arch Capital Group Ltd by 41.5% during the fourth quarter, selling 1,136,106 shares. The Swiss financial institution now holds 1,602,412 shares, representing approximately 0.44% of the Bermuda-based insurer valued at $153.7 million. While UBS reduced its position, several other institutional investors, including WealthCollab LLC and TD Waterhouse Canada Inc, increased their stakes in the company during the third and fourth quarters.
UBS Group AG raises LPL Financial Holdings Inc position by 27.6% in fourth quarter
UBS Group AG increased its holdings in LPL Financial Holdings Inc by 27.6% during the fourth quarter, purchasing an additional 92,627 shares to own a total of 428,755 shares valued at approximately $153.14 million. This filing represents 0.54% of LPL Financial's total market value. Other institutional investors, including Steigerwald Gordon & Koch Inc and SJS Investment Consulting Inc, also significantly increased their stakes in the financial services provider during the same period.
UBS Group AG increases stake in VeriSign Inc
UBS Group AG increased its holding in VeriSign Inc by 191.6% in the fourth quarter, purchasing an additional 411,728 shares to own 626,570 shares valued at $152.2 million. Other institutional investors, including Salomon & Ludwin LLC and Sunbelt Securities Inc, also adjusted their positions. VeriSign reported quarterly earnings of $2.34 per share, beating estimates, with revenue of $428.90 million. The company declared a quarterly dividend of $0.81 per share payable on May 27th. Analysts maintain a moderate buy consensus with a target price of $317.67.
UBS Group AG reduces Carlyle Group Inc holdings by 37.2% in fourth quarter
UBS Group AG decreased its stake in Carlyle Group Inc by 37.2% during the fourth quarter, selling 1,500,719 shares. The Swiss financial services firm now holds 2,536,538 shares, representing approximately 0.70% of the company valued at $149,935,000. While UBS reduced its position, several other institutional investors, including DMC Group LLC and HB Wealth Management LLC, increased their holdings in the third and fourth quarters. Carlyle Group reported earnings of $1.01 per share for the quarter, missing analyst estimates, though revenue increased 84.1% year-over-year.
UBS Group AG raises stock position in First Citizens BancShares
UBS Group AG increased its holdings in First Citizens BancShares, Inc. by 96.7% during the fourth quarter, acquiring an additional 34,184 shares. The firm now owns 69,551 shares valued at approximately $149.27 million, representing 0.56% of the company. Other institutional investors, including SBI Securities, UMB Bank, and Mirae Asset, also adjusted their positions in the third and fourth quarters. First Citizens BancShares reported quarterly earnings of $44.86 EPS, beating estimates, and declared a quarterly dividend of $2.10 payable on June 15th. Analyst consensus remains a 'Hold' with a price target of $2,202.08.
UBS Group AG increases stake in Imperial Oil Limited
UBS Group AG raised its holdings in Imperial Oil Limited by 21.6% during the fourth quarter, purchasing an additional 303,286 shares to own a total of 1,709,910 shares valued at approximately $147.58 million. Other institutional investors, including Westside Investment Management Inc. and Smartleaf Asset Management LLC, also increased their stakes in the Canadian energy company during the third and fourth quarters. As of the filing, 20.74% of Imperial Oil's stock is owned by institutional investors and hedge funds.
UBS Group AG increases stake in TechnipFMC plc by 20.3% in fourth quarter
UBS Group AG increased its position in TechnipFMC plc shares by 20.3% during the fourth quarter, acquiring an additional 555,441 shares. The fund now holds 3,290,658 shares, representing approximately 0.81% of the company and valued at $146.63 million. TechnipFMC, an oil and gas services firm, reported Q1 earnings of $0.64 per share, beating analyst estimates, though revenue slightly missed expectations. The company declared a quarterly dividend payable on June 3rd. Other institutional investors also adjusted their stakes, while insiders sold shares recently.
UBS Group AG increases Manulife Financial Corp holdings by 10.0%
UBS Group AG increased its stake in Manulife Financial Corp by 10.0% in the fourth quarter, purchasing an additional 363,963 shares to own 4,016,230 shares valued at $145.7 million. Other institutional investors, including MUFG Securities EMEA plc and Brighton Jones LLC, also raised their positions. Manulife Financial reported quarterly earnings of $0.80 per share, beating estimates, and declared a quarterly dividend of $0.485 per share. Analysts maintain an average 'Buy' rating with a price target of $51.50.
UBS Group AG raises holdings in ASE Technology Holding Co Ltd
UBS Group AG increased its stake in ASE Technology Holding Co Ltd by 11.4% in the fourth quarter, purchasing an additional 922,692 shares to hold a total of 9,038,322 shares valued at $145,517,000. Other institutional investors including Bank of America Corp DE, Rafferty Asset Management LLC, Schroder Investment Management Group, Goldman Sachs Group Inc, and Cullen Capital Management LLC also raised their positions in the semiconductor company during recent quarters. ASE Technology reported earnings of $0.20 per share, beating analyst estimates, with revenue of $5.43 billion for the quarter.
UBS Group AG cuts stake in Royal Bank of Canada
UBS Group AG reduced its position in Royal Bank of Canada by 3.0% during the fourth quarter, selling 25,885 shares. The Swiss financial institution now holds 846,903 shares, representing a 0.06% stake valued at approximately $144.4 million. While UBS decreased its holdings, other institutional investors including Brighton Jones LLC, AQR Capital Management LLC, and Baird Financial Group Inc. increased their stakes in the Canadian bank during various recent quarters.
UBS Group AG raises Woodward Inc stock position by 27% in fourth quarter
UBS Group AG increased its holdings in Woodward Inc by 27% during the fourth quarter, purchasing an additional 102,066 shares to own 480,031 shares valued at $145.12 million. This represents 0.80% of the company's stock. Other institutional investors also modified their stakes, while insiders including CEO Charles P. Blankenship and Director John D. Cohn sold shares totaling $10.2 million in the last three months. Analysts maintain a moderate buy rating with an average price target of $387.00.
UBS Group AG sells 899,580 shares of The Cooper Companies
UBS Group AG reduced its holdings in The Cooper Companies, Inc. by 33.8% in the fourth quarter, selling 899,580 shares. The Swiss financial institution now owns 1,760,530 shares, representing 0.90% of the medical device company valued at $144,293,000. While UBS sold, other institutional investors including Bell Investment Advisors Inc and True Wealth Design LLC increased their stakes. The Cooper Companies reported earnings of $1.10 per share, beating estimates, with revenue up 6.2% year-over-year.
UBS Group AG lowers holdings in Roper Technologies
UBS Group AG reduced its stake in Roper Technologies, Inc. by 33.8% in the fourth quarter, selling 163,149 shares to hold 320,054 shares valued at $142.47 million. While UBS decreased its position, other institutional investors including Vanguard Group Inc. and Mattern Capital Management LLC increased their stakes. The article also notes recent analyst rating changes and the company's quarterly earnings results.
UBS Group AG increases Crown Holdings stake by 27.1% in fourth quarter
UBS Group AG acquired an additional 297,208 shares of Crown Holdings, Inc. during the fourth quarter, boosting its position by 27.1% to 1,394,356 shares. The investment, valued at approximately $143.58 million, represents a 1.21% ownership stake. Other institutional investors, including Hennessy Advisors and OLD National Bancorp, also adjusted their holdings. Meanwhile, Crown Holdings reported quarterly earnings of $1.86 per share, beating estimates, and announced a quarterly dividend of $0.35 per share payable on May 28th.
UBS Group AG increases stake in EMCOR Group Inc
UBS Group AG increased its holdings in EMCOR Group Inc by 31.8% in the fourth quarter, acquiring an additional 55,071 shares to own a total of 228,188 shares valued at approximately $139.6 million. This represents a 0.51% stake in the construction company. Other institutional investors, including Great Lakes Advisors, Geneos Wealth Management, Sivia Capital, Baird Financial, and Bank of Nova Scotia, also adjusted their positions during the reporting periods. EMCOR Group recently reported strong Q1 results with record revenue and raised its fiscal 2026 guidance.
UBS Group AG raises stake in Comfort Systems USA
UBS Group AG increased its holdings in Comfort Systems USA, Inc. by 20.9% during the fourth quarter, purchasing an additional 26,605 shares to own 153,734 shares valued at $143.478 million. Other institutional investors also adjusted their positions. Meanwhile, insiders including Director Franklin Myers and CFO William George III sold shares totaling $56.276 million in the last 90 days. The company reported strong quarterly earnings with $10.51 EPS and declared a dividend increase to $0.80 per share.
UBS Group AG reduces Smurfit Westrock holdings by 67.8% in fourth quarter
UBS Group AG reduced its position in Smurfit Westrock PLC by 67.8% in the fourth quarter, selling 7,619,476 shares to hold 3,620,677 shares valued at $140.01 million. While UBS decreased its stake, other institutional investors including Barclays PLC, Massachusetts Financial Services Co. MA, and Sound Income Strategies LLC increased their positions. Smurfit Westrock reported Q1 revenue of $7.712 billion and EPS of $0.33, which missed analyst expectations. The company also declared a quarterly cash dividend of $0.4523 per share.
UBS Group AG increases stake in Neurocrine Biosciences
UBS Group AG increased its holdings in Neurocrine Biosciences, Inc. by 169.8% in the fourth quarter, purchasing an additional 618,956 shares. The fund now owns 983,528 shares valued at $139,494,000, representing 0.99% of the company. Other institutional investors, including Royal Bank of Canada and MIRAE ASSET, also raised their stakes. Neurocrine Biosciences reported quarterly earnings of $1.88 per share, missing analyst estimates, though revenue grew 28.3% year-over-year.
UBS Group AG increases stake in Western Midstream Partners
UBS Group AG increased its holdings in Western Midstream Partners, LP by 5.0% during the fourth quarter, purchasing an additional 165,726 shares. The Swiss financial institution now owns 3,501,784 shares valued at $138.32 million, representing approximately 0.86% of the pipeline company. This filing was submitted to the Securities and Exchange Commission. Other institutional investors also adjusted their positions in the second quarter.
UBS Group AG raises position in ATI Inc by 143.3% in fourth quarter
UBS Group AG increased its stake in ATI Inc by 143.3% during the fourth quarter, acquiring an additional 702,656 shares to hold a total of 1,193,129 shares valued at approximately $136.9 million. Other institutional investors, including Capital World Investors and Holocene Advisors LP, also raised their holdings. Analyst consensus remains 'Buy' with a target price of $152.88, following recent earnings that beat estimates. The company also authorized a $500 million share buyback program.